STOCK TITAN

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference, scheduled for September 12-14, 2022, at the Lotte New York Palace Hotel. Numinus will present on September 13 at 9:00 a.m. ET. Interested attendees can register here. Numinus is dedicated to advancing mental health care through innovative and evidence-based psychedelic-assisted therapies.

Positive
  • None.
Negative
  • None.

VANCOUVER, BC, Aug. 31, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. 

Numinus will present on Tuesday, September 13th at 9:00 a.m. ET. To attend, please register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate H.C. Wainwright representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About Numinus

Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedInFacebookTwitter, and Instagram.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-24th-annual-global-investment-conference-on-september-12-14-2022-301615370.html

SOURCE Numinus Wellness Inc.

FAQ

When is Numinus participating in the H.C. Wainwright Conference?

Numinus will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022.

What time will Numinus present at the H.C. Wainwright Conference?

Numinus will present on September 13, 2022, at 9:00 a.m. ET.

Where is the H.C. Wainwright Conference being held?

The conference will take place at the Lotte New York Palace Hotel in New York City.

How can I attend Numinus' presentation at the conference?

You can register to attend Numinus' presentation at the H.C. Wainwright Conference by clicking here.

What is Numinus Wellness focused on?

Numinus Wellness focuses on developing innovative mental health care and providing access to safe, evidence-based psychedelic-assisted therapies.

NUMINUS WELLNESS INC

OTC:NUMIF

NUMIF Rankings

NUMIF Latest News

NUMIF Stock Data

10.90M
309.90M
3.85%
2.67%
Medical Care Facilities
Healthcare
Link
United States of America
Vancouver